These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 15736462)

  • 1. Clinical response following adjuvant Temozolomide in a patient with primary cerebral lymphoma.
    Strik HM; Spreer A; Nagel H; Jacob S; Jung W; Kitze B; Bähr M
    Anticancer Res; 2004; 24(6):4121-5. PubMed ID: 15736462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: a patient with primary CNS lymphoma treated with temozolomide to complete response.
    Lerro KA; Lacy J
    J Neurooncol; 2002 Sep; 59(2):165-8. PubMed ID: 12241110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoradiotherapy with temozolomide after high-dose methotrexate for primary CNS lymphoma: a multicenter phase I study of a response-adapted strategy.
    Chiesa S; Hohaus S; Falcinelli L; D'Alò F; Martelli MF; Manfrida S; Beghella Bartoli F; Colosimo C; Valentini V; Aristei C; Balducci M
    Ann Hematol; 2020 Oct; 99(10):2367-2375. PubMed ID: 32816079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage therapy with temozolomide in an immunocompetent patient with primary brain lymphoma.
    Reni M; Ferreri AJ; Landoni C; Villa E
    J Natl Cancer Inst; 2000 Apr; 92(7):575-6. PubMed ID: 10749917
    [No Abstract]   [Full Text] [Related]  

  • 6. Complete response to temozolomide treatment in an elderly patient with recurrent primary central nervous system lymphoma--case report.
    Makino K; Nakamura H; Kudo M; Takeshima H; Kuratsu J
    Neurol Med Chir (Tokyo); 2007 May; 47(5):229-32. PubMed ID: 17527051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Temozolomide in patients with a glioblastoma multiforme: new developments].
    Bromberg JE; Postma TJ
    Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1376-8. PubMed ID: 15997689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temozolomide for relapsed primary CNS lymphoma.
    Osmani AH; Masood N
    J Coll Physicians Surg Pak; 2012 Sep; 22(9):594-5. PubMed ID: 22980617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single centre study of the treatment of relapsed primary central nervous system lymphoma (PCNSL) with single agent temozolomide.
    Wong SF; Gan HK; Cher L
    J Clin Neurosci; 2012 Nov; 19(11):1501-5. PubMed ID: 22995759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
    Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
    Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme.
    Chamberlain MC; Tsao-Wei DD
    Cancer; 2004 Mar; 100(6):1213-20. PubMed ID: 15022289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-grade gliomas: results in patients treated with adjuvant radiotherapy alone and with adjuvant radio-chemotherapy.
    Valeriani M; Ferretti A; Franzese P; Tombolini V
    Anticancer Res; 2006; 26(3B):2429-35. PubMed ID: 16821628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant temozolomide: how long and how much?
    Franceschi E; Tosoni A; Brandes AA
    Expert Rev Anticancer Ther; 2008 May; 8(5):663-5. PubMed ID: 18471038
    [No Abstract]   [Full Text] [Related]  

  • 14. Adding concomitant and adjuvant temozolomide to radiotherapy does not reduce health-related quality of life in people with glioblastoma.
    Hamilton DA
    Cancer Treat Rev; 2006 Oct; 32(6):483-6. PubMed ID: 16730911
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations.
    Chinot OL; Barrie M; Frauger E; Dufour H; Figarella-Branger D; Palmari J; Braguer D; Hoang-Xuan K; Moktari K; Peragut JC; Martin PM; Grisoli F
    Cancer; 2004 May; 100(10):2208-14. PubMed ID: 15139066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Temozolomide as therapeutic option for patients with metastatic melanoma and poor prognosis].
    Frick S; Lischner S; Rosien F; Haacke TC; Schäfer F; Christophers E; Hauschild A
    Hautarzt; 2002 Oct; 53(10):659-65. PubMed ID: 12297947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temozolomide: a novel oral alkylating agent.
    Danson SJ; Middleton MR
    Expert Rev Anticancer Ther; 2001 Jun; 1(1):13-9. PubMed ID: 12113120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas.
    Sipos L; Vitanovics D; Afra D
    Ideggyogy Sz; 2004 Nov; 57(11-12):394-9. PubMed ID: 15662767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experience.
    Jalali R; Basu A; Gupta T; Munshi A; Menon H; Sarin R; Goel A
    Br J Neurosurg; 2007 Dec; 21(6):583-7. PubMed ID: 18071985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Favourable result for temozolomide in recurrent high-grade glioma].
    Taal W; van der Rijt CD; Sillevis Smitt PA; Kros JM; van Heuvel I; Enting RH; van den Bent MJ
    Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1393-9. PubMed ID: 15997692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.